Market Summary
Wall Street ended a three-day losing streak with modest gains as the S&P 500 rose 0.2% following stable core PCE inflation data. Tech stocks led the rebound, helped by Nvidia’s AI momentum and strong earnings, despite tariff fears and political uncertainties fueling cautious sentiment.
President Trump intensifies trade war with sweeping new tariffs on pharmaceuticals, heavy trucks, and furniture, sparking market and international reactions.
Figure of the Day
100% – Tariff rate imposed by U.S. on imported patented pharmaceuticals starting October 1, 2025.
Electronic Arts nears a landmark $50 billion leveraged buyout, signaling a major shift for the video game giant as investor interest surges.
U.S. political landscape roiled by James Comey indictment, intensifying President Trump’s legal battles and signaling a new phase of political prosecutions.
Bullish
Big Pharma Stocks Rally After Trump’s Tariff Plan Sparks Investor Optimism
Despite broad tariff threats, major pharmaceutical stocks rose on Wall Street as investors anticipate potential manufacturing investments and exemptions, showcasing resilience amid trade tensions.
More on bostonherald.com
Federal Reserve signals inflation remains stubborn as PCE price index rises slightly, complicating policy outlook amid political tariff pressures.
Microsoft restricts Israel’s military access to sensitive Azure and generative AI services amid surveillance allegations, reflecting tech’s geopolitical challenges.
Bearish
Small Biotech Firms Face Uncertainty Under Trump’s New Pharma Tariffs
Smaller biotech companies are bracing for vulnerability as President Trump’s new 100% tariffs on imported patented drugs threaten to disrupt business amid manufacturing requirements exemptions favoring large firms.
More on wsj.com
Household spending data shows resilience despite consumer sentiment dips; savings rates fall, indicating spending outpaces income growth.
Starbucks faces widespread store closures amid restructuring efforts as customer traffic declines, sparking industry-wide concern about its turnaround plans.
Regulatory Impact
Trump administration announced new tariffs imposing 100% duties on imported branded pharmaceuticals unless manufacturers build factories in the U.S., along with tariffs on heavy trucks and home furnishings, starting Oct 1.
Artificial intelligence sector boom fuels massive investments and workforce expansions at major firms like Nvidia and Anthropic, shaping tech and financial markets.
Government shutdown risks rise amid congressional gridlock, with Senate GOP leaders warning of impasse despite last-minute efforts to prevent a crisis.
Quote
Trump’s aggressive tariff moves are about protecting American jobs and industry — and making us strong again.
— President Donald Trump
US international relations strain with visa revocation of Colombian President and ambassador recalls by Iran amid mounting diplomatic tensions.
Companies brace for fallout from Trump’s new pharmaceutical tariffs with big pharma stocks holding steady while smaller biotech firms face vulnerability.
Electronic Arts’ $50 billion privatization talks gain momentum with participation from major investors including Jared Kushner’s private equity group.
Supreme Court delivers multiple ruling wins for President Trump, allowing continuation of foreign aid freezes amid ongoing legal battles.
The Biden administration faces mounting political and legal pressures with controversies around health officials and vaccine policies igniting public debate.
Walmart warns consumers on listeria contamination in ready-to-eat pasta meals amid a linked deadly outbreak, prompting national health alerts.
Amazon faces a historic $2.5 billion FTC settlement over deceptive Prime subscription tactics, promising refunds to millions of subscribers.
Supply chain and automotive sectors are hit by major recalls and security breaches, including BMW fire risk recalls and ransomware impacts on Volvo North America.
TikTok U.S. business sale advances amid valuation debates, with investment groups including Dubai-backed funds joining the ownership consortium.